<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Epstein-Barr virus (EBV) is associated with various malignant and benign <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It also efficiently transforms human B lymphocytes in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>The latent membrane protein 1 (LMP1) of EBV-infected cells plays a central part in this process by mimicking members of the family of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) receptors, thereby transmitting growth signals from the cell membrane to the nucleus through cytoplasmic TNF-receptor-associated factors (TRAFs) </plain></SENT>
<SENT sid="3" pm="."><plain>I sought evidence of LMP1-mediated signal transduction through TRAFs in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue from patients with post-transplantation <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> related to the acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The association of LMP1 with TRAF-1 or TRAF-3 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue was studied with double-immunofluorescence microscopy and immunoprecipitation assays </plain></SENT>
<SENT sid="5" pm="."><plain>Evidence of LMP1-TRAF signaling was sought with an electrophoretic mobility shift assay for the nuclear factor-kappaB (NF-kappaB) transcription factor </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> from eight patients with post-transplantation <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e>, two patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and three patients with endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were analyzed </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> from six of the patients with post-transplantation <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> were positive for EBV and expressed LMP1; two samples were EBV-negative </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> from both patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were EBV-positive and expressed LMP1, whereas <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from <z:hpo ids='HP_0000001'>all</z:hpo> three patients with <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumors</z:e> were positive for EBV but negative for LMP1 </plain></SENT>
<SENT sid="9" pm="."><plain>Double-immunofluorescence microscopy showed that LMP1 localized with and immunoprecipitated with TRAF-1 and TRAF-3 in <z:hpo ids='HP_0000001'>all</z:hpo> eight of the EBV-positive, LMP1-positive samples </plain></SENT>
<SENT sid="10" pm="."><plain>An electrophoretic mobility shift assay revealed activated NF-kappaB in <z:hpo ids='HP_0000001'>all</z:hpo> eight EBV-positive, LMP1-positive samples as well, but not in either of the EBV-negative, LMP1-negative samples or in the three EBV-positive, LMP1-negative samples </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: LMP1-mediated signaling through the TRAF system has a role in the pathogenesis of the EBV-positive <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that arise in immunosuppressed patients </plain></SENT>
</text></document>